Production of iron-enriched yeast and it's application in the treatment of iron-deficiency anemia

Ying Chen,Yuanxiang Pang,Hongbing Wan,Xinyi Zhou,Mingli Wan,Shengshuo Li,Xuelian Liu

DOI: https://doi.org/10.1007/s10534-024-00592-3

2024-03-30

BioMetals

Abstract:Iron deficiency anemia (IDA) is one of the most serious forms of malnutrition. Wild type strains of Saccharomyces cerevisiae have higher tolerance to inorganic iron and higher iron conversion and accumulation capacity. The aim of this study was to investigate the effect of S. cerevisiae enriched iron as a potential organic iron supplement on mice with iron deficiency anemia. 60 male Kunming mice (KM mice, with strong adaptability and high reproduction rate, it can be widely used in pharmacology, toxicology, microbiology and other research) were randomly divided into normal control group and iron deficiency diet model group to establish IDA model. After the model was established, IDA mice were randomly divided into 5 groups: normal control group, IDA group, organic iron group (ferrous glycinate), inorganic iron group (ferrous sulfate) and S. cerevisiae enriched iron group. Mice in the experimental group were given different kinds of iron by intragastric administration once a day for 4w. The results showed that S. cerevisiae enriched iron had an effective recovery function, and the body weight and hematological parameters of IDA mice returned to normal levels. The activities of superoxide dismutase, glutathione peroxidase and total antioxidant capacity in serum were increased. In addition, the strain no. F8, able to grow in an iron-rich environment, was more effective in alleviating IDA and improving organ indices with fewer side effects compared to ferrous glycinate and ferrous sulfate groups. This study suggests that the iron-rich strain no. F8 may play an important role in improving IDA mice and may be developed as a new iron supplement.

biochemistry & molecular biology

What problem does this paper attempt to address?

The paper aims to address the issue of iron deficiency anemia (IDA) and explore the efficacy and safety of using iron-rich brewer's yeast (Saccharomyces cerevisiae) as an organic iron supplement.

Specifically, the main objectives of the study include:
1. **Evaluate the effect of iron-rich brewer's yeast on IDA mice**: Observe the impact of iron-rich brewer's yeast on hematological parameters (such as hemoglobin levels, red blood cell count, etc.) in IDA mice through experiments.
2. **Compare the effects of different iron supplements**: Compare iron-rich brewer's yeast with traditional iron supplements (such as ferrous sulfate and ferrous glycinate) to assess their effectiveness in improving IDA.
3. **Evaluate antioxidant capacity**: Study the effect of iron-rich brewer's yeast on the activity of antioxidant enzymes and total antioxidant capacity in IDA mice.
4. **Safety assessment**: Evaluate the safety of different iron supplements through histopathological examination and other physiological indicators, particularly the potential side effects caused by ferrous sulfate.

Overall, this paper attempts to demonstrate that iron-rich brewer's yeast, as a novel iron supplement, has better efficacy and lower side effects in the treatment of IDA.